Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Neurology  |  Psychiatry/Psychology

Search Medical Condition
Please enter condition
Please choose location
 

Memory Loss Clinical Trials

A listing of Memory Loss medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (52) clinical trials

Meridien Research is participating in a nationwide research study evaluating the safety and effectiveness of an investigational medication, AC-1204, for those with mild to moderate Alzheimer's disease.

Phase N/A

California Neuroscience Research is conducting a research study on the effectiveness and safety of an investigational medication or placebo in patients with mild Alzheimer’s disease. The study has up to 31 office visits over up to 40 months. Participants will receive an investigational medication or placebo monthly by subcutaneous injection. ...

Phase N/A

Glendale PAREXEL Early Phase is conducting a research study for individuals with Alzheimer's Disease or Mild Cognitive Impairment (MCI). The study involves two screening visits; and if you qualify, there may be two (2) in-house stays and five (5) follow-up visits. Volunteers that qualify may be compensated up to $5,640 ...

Phase

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A

A Research Study is being conducted to evaluate an oral investigational medication that may help slow down the progression of what could be very early Alzheimer’s disease. Prodromal Alzheimer’s disease is the very early stage of the disease when minor symptoms first appear. A diagnosis can only be confirmed through ...

Phase N/A

This Phase III study is designed as a randomized, double-blinded, placebo-controlled study for subjects with evidence of early AD. The study will evaluate safety and tolerability, efficacy as measured by CDR-SB, and will determine if the combination therapy ALZT-OP1 will slow down, arrests, or reverse cognitive and functional decline in ...

Phase

An evaluation of an imaging agent used in PET scans to detect changes in the brain that occur in individuals with Alzheimer's disease compared to healthy volunteers.

Phase N/A

An exploratory, paired biomarker study in subjects with Alzheimer's disease vs. healthy subjects

Phase N/A

Primary objective: to evaluate the efficacy of AZD3293 on cognitive and functional outcomes in patients with early Alzheimer’s disease (AD) as measured by the Clinical Dementia Rating - Sum of Boxes (CDR-SB) score. Early AD is defined as the continuum of patients with mild cognitive impairment (MCI) due to AD ...

Phase N/A